Latest News and Press Releases
Want to stay updated on the latest news?
-
Austin, TX, USA, May 29, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Lithography Equipment Market Size, Trends and Insights By Technology (Mask...
-
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Cardiac Ablation Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024...
-
Omaha, Neb., April 08, 2024 (GLOBE NEWSWIRE) -- Nebraska Medicine patient Doris McCann found out something wasn't right with her heart when she got an Apple Watch for Christmas. "I started getting...
-
Austin, TX, USA, April 03, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Liver Cancer Market Size, Trends and Insights By Type (Hepatocellular Carcinoma...
-
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "Global Radiofrequency Ablation Devices Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The...
-
Westport, CT, Feb. 20, 2024 (GLOBE NEWSWIRE) -- -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company, today announced that it has terminated a...
-
Westport, CT, Feb. 06, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company committed to delivering unprecedented accuracy and...
-
Westport, CT, Jan. 31, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company committed to delivering unprecedented accuracy and...
-
Cost Savings Targeted to Reduce Cash Burn by 50% Core Strategy Shifts to Business Development and Distribution Partnerships Westport, CT, Jan. 30, 2024 (GLOBE NEWSWIRE) -- BioSig...
-
Wilmington, Delaware, United States, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global tumor ablation market was projected to attain US$ 1.3 billion in 2022. It is...